Free Trial

Ondine Biomedical (OBI) Competitors

Ondine Biomedical logo
C$15.30 +0.30 (+2.00%)
As of 11:50 AM Eastern

OBI vs. HZD, PRTC, VRP, AVCT, FARN, ARIX, CIR, 4BB, BVXP, and TILS

Should you be buying Ondine Biomedical stock or one of its competitors? The main competitors of Ondine Biomedical include Horizon Discovery Group plc (HZD.L) (HZD), PureTech Health (PRTC), Verona Pharma plc (VRP.L) (VRP), Avacta Group (AVCT), Faron Pharmaceuticals Oy (FARN), Arix Bioscience (ARIX), Circassia Group (CIR), 4basebio (4BB), Bioventix (BVXP), and Tiziana Life Sciences (TILS). These companies are all part of the "biotechnology" industry.

Ondine Biomedical vs. Its Competitors

Horizon Discovery Group plc (HZD.L) (LON:HZD) and Ondine Biomedical (LON:OBI) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations, institutional ownership and media sentiment.

Horizon Discovery Group plc (HZD.L) has higher revenue and earnings than Ondine Biomedical. Ondine Biomedical is trading at a lower price-to-earnings ratio than Horizon Discovery Group plc (HZD.L), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Horizon Discovery Group plc (HZD.L)£54.63M0.00N/A-£5.50N/A
Ondine BiomedicalC$2.05M3,864.70-C$424.66K-C$0.07-218.57

23.0% of Ondine Biomedical shares are owned by institutional investors. 37.3% of Ondine Biomedical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Horizon Discovery Group plc (HZD.L) has a net margin of 0.00% compared to Ondine Biomedical's net margin of -873.84%. Horizon Discovery Group plc (HZD.L)'s return on equity of 0.00% beat Ondine Biomedical's return on equity.

Company Net Margins Return on Equity Return on Assets
Horizon Discovery Group plc (HZD.L)N/A N/A N/A
Ondine Biomedical -873.84%-684.01%-159.71%

In the previous week, Ondine Biomedical had 2 more articles in the media than Horizon Discovery Group plc (HZD.L). MarketBeat recorded 2 mentions for Ondine Biomedical and 0 mentions for Horizon Discovery Group plc (HZD.L). Ondine Biomedical's average media sentiment score of 0.70 beat Horizon Discovery Group plc (HZD.L)'s score of 0.00 indicating that Ondine Biomedical is being referred to more favorably in the news media.

Company Overall Sentiment
Horizon Discovery Group plc (HZD.L) Neutral
Ondine Biomedical Positive

Summary

Horizon Discovery Group plc (HZD.L) and Ondine Biomedical tied by winning 5 of the 10 factors compared between the two stocks.

Get Ondine Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for OBI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OBI vs. The Competition

MetricOndine BiomedicalBiotechnology IndustryMedical SectorLON Exchange
Market CapC$7.92BC$238.03MC$5.78BC$2.58B
Dividend YieldN/A3.78%5.73%5.30%
P/E Ratio-218.5741.2574.865,404.14
Price / Sales3,864.704,870.38543.7896,701.95
Price / Cash1.9913.1925.8127.93
Price / Book1,771.93126.0413.258.78
Net Income-C$424.66K-C$90.99MC$3.29BC$5.89B
7 Day Performance0.33%2.35%0.47%0.56%
1 Month Performance-5.03%21.81%4.60%44.71%
1 Year Performance131.82%657.62%73.42%174.03%

Ondine Biomedical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OBI
Ondine Biomedical
N/AC$15.30
+2.0%
N/A+127.3%C$7.92BC$2.05M-218.57N/ANews Coverage
Gap Up
High Trading Volume
HZD
Horizon Discovery Group plc (HZD.L)
N/AN/AN/AN/A£302.98M£54.63M-33.55416
PRTC
PureTech Health
2.0621 of 5 stars
GBX 114.70
-0.6%
GBX 455
+296.7%
-22.3%£277.21M£6.17M674.71300
VRP
Verona Pharma plc (VRP.L)
N/AN/AN/AN/A£228MN/A-1.6822Gap Up
AVCT
Avacta Group
N/AGBX 53.41
-2.9%
N/A-26.7%£214.59M£113K-348.18120
FARN
Faron Pharmaceuticals Oy
N/AGBX 189.95
+1.3%
N/A-14.0%£212.66MN/A-703.5234
ARIX
Arix Bioscience
N/AN/AN/AN/A£183.73M£14.16M1,290.919
CIR
Circassia Group
N/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down
4BB
4basebio
N/AGBX 850
-0.6%
GBX 1,600
+88.2%
-42.1%£131.62M£933K-904.26101
BVXP
Bioventix
N/AGBX 2,405
-1.4%
N/A-35.2%£125.66M£13.66M1,623.6812
TILS
Tiziana Life Sciences
N/AN/AN/AN/A£113.85M-£3.60M-3.5911Positive News

Related Companies and Tools


This page (LON:OBI) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners